Skip to main content
Logo FCRIN4MS
Logo FCRIN4MS National Network for Clinical Research on Multiple Sclerosis and Rare Inflammatory Diseases of the Central Nervous System
National Network for Clinical Research on Multiple Sclerosis and Rare Inflammatory Diseases of the Central Nervous System
  • Clinical trials of the network
  • fr
  • The network
    • Who are we?
    • Our expertise
    • Working with FCRIN4MS
  • Clinical research activities
    • To participate in a clinical trial
    • Our projects
  • Our training
    • Capsules
  • Map of the network
  • Media
    • News
    • Press
Discover F-CRIN

Follow us

  • LinkedIn
  • Contact

Breadcrumb

  1. Home
  2. Media
  3. News

News

All news from F-CRIN

Multiple sclerosis: positive results with vitamin D to treat the disease

F-CRIN

27 March 2025

Multiple sclerosis: positive results with vitamin D to treat the disease

F-CRIN

26 February 2025

F-CRIN supports the Giens 2025 National Workshop Feedback Day

F-CRIN

25 February 2025

ICTD 2025: registration now open!

F-CRIN

31 January 2025

International Clinical Trials Day 2025: rethinking clinical trials for greater inclusiveness

F-CRIN

24 January 2025

Vincent Diebolt: "2025, a pivotal year for F-CRIN".

F-CRIN

16 September 2024

3 questions to the MUST network

F-CRIN

13 June 2024

Symposium "Next generation in clinical research: AI, in silico and external arms, Time to make them real" - June 24, 2024 in Lille (France)

F-CRIN

04 October 2023

3rd CTU Day ECRIN - December 4, 2023

F-CRIN

06 June 2023

Switzerland acquires ECRIN member status

F-CRIN

16 May 2023

ECRIN welcomes its newest member: GREECE

Pagination

  • First page « Premier
  • Previous page ‹‹
  • Page 1
  • Current page 2
  • Page 3
  • Next page ››
  • Last page Dernier »

Institut du Cerveau - ICM
Groupe hospitalier Pitié-Salpêtrière
47-83, bd de l'Hôpital
75651 Paris CEDEX 13

Téléphone : + 33 (0)1 42 16 57 77

Menu de gauche

  • ARSEP
  • OFSEP
  • SFSEP

Menu de droite

  • Contact
  • Cookies
  • Legal notices

Register to the newsletter

Subscribe

Follow us

  • LinkedIn